Does SECUKINUMAB Cause Haemoptysis? 103 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 103 reports of Haemoptysis have been filed in association with SECUKINUMAB (COSENTYX). This represents 0.1% of all adverse event reports for SECUKINUMAB.
103
Reports of Haemoptysis with SECUKINUMAB
0.1%
of all SECUKINUMAB reports
2
Deaths
33
Hospitalizations
How Dangerous Is Haemoptysis From SECUKINUMAB?
Of the 103 reports, 2 (1.9%) resulted in death, 33 (32.0%) required hospitalization, and 8 (7.8%) were considered life-threatening.
Is Haemoptysis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 103 reports have been filed with the FAERS database.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Haemoptysis?
RIVAROXABAN (1,961)
ASPIRIN (1,255)
APIXABAN (846)
TREPROSTINIL (838)
ALBUTEROL (652)
CLOPIDOGREL BISULFATE (643)
PREDNISONE (618)
WARFARIN (555)
ADALIMUMAB (472)
TIOTROPIUM (462)
Which SECUKINUMAB Alternatives Have Lower Haemoptysis Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG